Home
>
National Drug Code (NDC)
>
Refludan
Refludan - 50419-150-57 - (lepirudin)
Drug Information of Refludan
| Product NDC: | 50419-150 |
| Proprietary Name: | Refludan |
| Non Proprietary Name: | lepirudin |
| Active Ingredient(s): | 50 mg/mL & nbsp; lepirudin |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | POWDER |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Refludan
| Product NDC: | 50419-150 |
| Labeler Name: | Bayer HealthCare Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020807 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20070309 |
Package Information of Refludan
| Package NDC: | 50419-150-57 |
| Package Description: | 10 VIAL in 1 BOX (50419-150-57) > 1 mL in 1 VIAL |
NDC Information of Refludan
| NDC Code | 50419-150-57 |
| Proprietary Name | Refludan |
| Package Description | 10 VIAL in 1 BOX (50419-150-57) > 1 mL in 1 VIAL |
| Product NDC | 50419-150 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | lepirudin |
| Dosage Form Name | POWDER |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20070309 |
| Marketing Category Name | NDA |
| Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
| Substance Name | LEPIRUDIN |
| Strength Number | 50 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] |
